Cascade genetic testing in families with hereditary cancer susceptibility: promise vs practice
Tectonic advances in precision oncology hold the promise of markedly improving the experience and outcomes of patients…
International Open Access Week 2022 – Webinars
-
from 24 to 30 October
#IDIBELLfellows: Romina Miranda / Marta Valle
07/10/2020 15:00-16:00
Room 205 – Nou aulari UB-Bellvitge
Microsoft Teams Meeting
#IDIBELLconnect: Novel clinical and translational research approaches to mesothelioma, an orphan tumor
Ernest Nadal
Group Leader at Bellvitge Biomedical Research Institute (IDIBELL), Clinical Research in Solid Tumors Group, Oncobell Program
Head of Section of Thoracic, Brain and Head and Neck Tumors, Catalan Institute of Oncology (ICO), Department of Medical Oncology
Associate Professor, University of Barcelona, Department of Clinical Sciences, Campus Bellvitge
09/10/2020 13:00-14:00
Microsoft Teams Meeting
Career Day 2020
21/10/2020 -
21-22 October 2020
This event is being held online
La recerca en temps de pandèmia
Dra. Maria Ángeles Domínguez
Dr. Xavier Solanich
21/10/2020 19:00-
VII Programa de excelencia en el abordaje del paciente con EM de alta actividad
Unitat EM HUB
22/10/2020 -
22-23 Octubre 2020
Sala d’actes Bellvitge University hospital 9.00h
#IDIBELLconnect: RANK a novel therapeutic target in breast cancer
Speaker Eva Gonzalez-Suarez
Transformation and Metastasis Group, Oncobell Program
06/11/2020 13:00-14:00
PhD Day 2020
12/11/2020 -
12-13 November 2020
this event is being held online
#IDIBELLconnect: Generation of protective immunity against infections by removing non-neutralizing/blocking antibodies
Rafael Máñez
Group Leader at the Bellvitge Biomedical Research Institute (IDIBELL), Innate Immunity and Pathology of the Critical Patient Group, Infectious disease and transplantation Program
Director of Intensive Care Department at Bellvitge University Hospital
20/11/2020 13:00-14:00
Microsoft Teams Meeting
Thesis: Osteoarticular infections: insights on bacteraemic clinical forms and antimicrobial alternatives against Pseudomonas aeruginosa from a translational perspective
By Joan Gómez Junyent
Directors: Javier Ariza Cardenal i Oscar Murillo Rubio
24/11/2020 12:00-
Xerrades Sinergia
Òscar Martínez Tirado
Marta Barrachina
Gabriela Jiménez
Anna Veiga
Esteve Fernandez
Susana Jiménez
Rafael Máñez
Mònica Povedano
Miquel Àngel Pujana
Laia Alemany
Montse Nacher
28/11/2020 10:00-19:00
Online i en directe:
https://sinergia.l-h.cat/
#IDIBELLconnect: The mTOR-LARP1 axis and the anabolic reservoir of tumor cells: A new therapeutic target in colorectal cancer and beyond
Antonio Gentilella
Metabolism and Cancer Group, Oncobell Program, Bellvitge Biomedical Research Institute (IDIBELL)
Department of Physiology and Biochemistry, Faculty of Pharmacy, University of Barcelona
04/12/2020 13:00-14:00
Microsoft Teams Meeting
#IDIBELLconnect: Immunotherapeutic potential of oncolytic Vaccinia viruses
Juan Jose Rojas
Bellvitge Biomedical Research Institute (IDIBELL)
Unitat d’Immunologia, Departament de Patologia i Terapèutica Experimental, Universitat de Barcelona
18/12/2020 13:00-14:00
Microsoft Teams Meeting
Thesis: Tumor-secreted cytokines in an in vivo model of lung cancer cachexia: A study of GDF-15 and LIF
Friday March 13, 10:00, sala de Graus UB Bellvitge Thesis: Tumor-secreted cytokines in an in vivo model…
#IDIBELLfellows: Paula Camps
Effect of prolonged azithromycin treatment on the fecal and respiratory microbiome of patients with severe COPD Paula…
Vascular Dysfunction in Disease: Decoding the Mechanochemical Feedbacks to Engineer Tissue Physiology
Hosted by Carlos Pérez-González – Cell plasticity and regeneration group
#Facultyseminars: GATA2 deficiency Syndrome: modeling progression to MDS
Patients with GATA2 deficiency are at high risk of developing myelodysplastic syndrome (MDS), which may progress to…
#IDIBELLseminars: Citizen Science at the Intersection of Health, Environment and Digital Innovation
Citizen science can accelerate the translation of data into public‑health action amid escalating climate pressures. This session…
Thesis: DGCR8 driven schwannomatosis: inheritance, tumor profiling and mechanistic insights
Friday February 27, 15:00, sala Pau Viladiu, hospital Duran i Reynals Thesis: DGCR8 driven schwannomatosis: inheritance, tumor…
#Facultyseminars: The TGF-beta pathway as a target to improve immunotherapy in hepatocellular carcinoma (HCC)
Liver cancer incidence has increased markedly in recent years, with high mortality rates and limited therapeutic options….
Llançament del nou programa de recerca en malalties minoritàries en adults
El 25 de febrer llancem el nou Programa de Recerca en Malalties Minoritàries d’Adults. El Campus de…
- 1
- 2
- 3
- …
- 42
- Entrades següents »